Arrhythmia
An Introduction to Arrhythmia
Advances in the understanding of arrhythmias has improved diagnosis and led to the discovery of new therapies. Large-scale studies into the direct oral anticoagulation treatment paradigm continue to improve patient selection, and technological advances such as hand-held ECG devices and implantable loop recorders have been shown to aid in arrhythmia detection.
Browse the content below where leading experts discuss the latest data in video interviews and short articles from our conference hub, and browse the selection of peer- reviewed articles from our journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Ventricular fibrillation (VF) is characterized by rapid (>300 beats a per minute), irregular electrical activation with variable electrocardiographic waveforms that prevents coordinated myocardial contraction, resulting in immediate loss of cardiac output.1 It most commonly occurs in the context of coronary ...
touchCARDIO Future Leaders 2026 Following the successful introduction last year of our touchCARDIO Future Leaders, we are delighted to announce that nominations are now open for the 2026 edition. This initiative celebrates the next generation of pioneers in cardiology, those whose passion, ...
At EHRA 2026, new research presented by Professor Elaine Chew explores how music-based digital tools can enhance arrhythmia detection and enable personalized, AI-driven approaches to cardiovascular diagnosis and therapy.
Dr Andreas Boehmer joins the Heart International Editorial Board with expertise in electrophysiology
We are pleased to announce the appointment of Dr Andreas Boehmer to the Heart International Editorial Board. Dr Boehmer is an Electrophysiology Fellow at St. Josefs-Hospital Wiesbaden in Germany, where he works within the Department of Cardiology and conducts research focused on interventional therapies for cardiac arrhythmias and the treatment of patients with tachycardiomyopathy.
The official abstracts from the Heart Rhythm Congress (HRC) 2025
S3E1_What impact does sleep have on physicians and their patients? We all know sleep is important, but what happens when physicians don’t get enough? In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from ...
Late-breaking data from ESC 2025 are set to reshape daily cardiology practice, with Dr José Luis Merino highlighting trials that challenge long-standing use of beta blockers, underscore the value of potassium optimization in ICD patients, and caution against routine aspirin in anticoagulated individuals, while also pointing to artificial intelligence as an emerging tool in clinical decision-making.
In this Q&A, Dr Camm shares his thoughts on how meaningful impacts can be made by early career cardiologists, the possibility of artificial intelligence (AI) for the future of cardiology and the entirety of medicine, and his hopes for the future.
Today, NICE recommended pulsed field ablation (PFA) for the treatment of atrial fibrillation (AF), the most common heart rhythm disorder, affecting around 2% of UK adults.
The touchCARDIO journal Heart International has once again seen an increase in its Journal Impact Factor (JIF), rising from 1.9 in 2024 to 2.3 in 2025.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
On April 25, 2025, the FDA approved the OmniaSecure defibrillation lead, a 1.6 mm, catheter-delivered, lumenless lead for right ventricular implantation. The small-diameter lead is designed to connect to an implantable defibrillator and treat ventricular tachyarrhythmias, ventricular fibrillation, and bradyarrhythmias, with LEADR trial data showing high implant success, safety, and electrical performance.
In this Q&A, he shares insights into his career journey, the experiences that shaped his path and what excites him most about the future of cardiology.
It is with pride and gratitude that we reflect on the remarkable 10-year journey of European Journal of Arrhythmia & Electrophysiology. With the vital contributions of all of our esteemed authors, reviewers and editorial board members, the journal has served ...
Postural tachycardia syndrome (PoTS) is a chronic condition, predominately affecting women between the ages of 15 and 50, and prevalence is estimated to be 0.2%.1,2 It is characterised by an abnormal response by the autonomic nervous system to changes in posture causing lightheadedness ...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
